(BK) The Bank of New York Mellon - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0640581007
Stock: Custody, Clearing, Investment, Treasury, Wealth
Total Rating 52
Risk 35
Buy Signal 1.02
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.65% |
| Yield on Cost 5y | 5.86% |
| Yield CAGR 5y | 11.37% |
| Payout Consistency | 91.6% |
| Payout Ratio | 22.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.9% |
| Relative Tail Risk | 0.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.48 |
| Alpha | 27.67 |
| Character TTM | |
|---|---|
| Beta | 0.864 |
| Beta Downside | 1.046 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.91% |
| CAGR/Max DD | 1.65 |
Description: BK The Bank of New York Mellon January 29, 2026
The Bank of New York Mellon (BK) delivers a broad suite of financial services-including custody, clearing, wealth management, and corporate treasury solutions-across four operating segments: Securities Services; Market and Wealth Services; Investment and Wealth Management; and Other. Its client base spans central banks, sovereigns, asset managers, insurers, corporations, and high-net-worth individuals worldwide.
Key recent metrics underline the firm’s scale and growth trajectory: FY 2023 revenue reached $16.0 billion, net income was $4.0 billion, and assets under custody (AUC) grew to $43 trillion, while assets under administration (AUA) topped $58 trillion. The custody business is benefitting from a 9% year-over-year increase in global ETF assets, and fee-based income is being bolstered by tighter regulatory requirements that drive demand for sophisticated middle-office and data-analytics services.
For a deeper quantitative view, consider exploring ValueRay’s analyst dashboards for BK.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 5.55b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 1.35 > 1.0 |
| NWC/Revenue: -291.4% < 20% (prev -292.0%; Δ 0.57% < -1%) |
| CFO/TA 0.01 > 3% & CFO 3.10b > Net Income 5.55b |
| Net Debt (-97.64b) to EBITDA (8.36b): -11.68 < 3 |
| Current Ratio: 0.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (704.7m) vs 12m ago -3.95% < -2% |
| Gross Margin: 50.62% > 18% (prev 0.46%; Δ 5016 % > 0.5%) |
| Asset Turnover: 8.83% > 50% (prev 9.51%; Δ -0.67% > 0%) |
| Interest Coverage Ratio: 0.25 > 6 (EBITDA TTM 8.36b / Interest Expense TTM 20.68b) |
Altman Z'' -1.08
| A: -0.24 (Total Current Assets 272.49b - Total Current Liabilities 386.86b) / Total Assets 472.30b |
| B: 0.10 (Retained Earnings 46.40b / Total Assets 472.30b) |
| C: 0.01 (EBIT TTM 5.21b / Avg Total Assets 444.18b) |
| D: 0.10 (Book Value of Equity 43.38b / Total Liabilities 427.49b) |
| Altman-Z'' Score: -1.08 = CCC |
Beneish M 1.00
| DSRI: 11.64 (Receivables 81.81b/7.08b, Revenue 39.24b/39.55b) |
| GMI: 0.91 (GM 50.62% / 45.98%) |
| AQI: 0.85 (AQ_t 0.42 / AQ_t-1 0.49) |
| SGI: 0.99 (Revenue 39.24b / 39.55b) |
| TATA: 0.01 (NI 5.55b - CFO 3.10b) / TA 472.30b) |
| Beneish M-Score: 5.56 (Cap -4..+1) = D |
What is the price of BK shares?
As of February 01, 2026, the stock is trading at USD 119.92 with a total of 3,059,623 shares traded.
Over the past week, the price has changed by +1.96%, over one month by +3.06%, over three months by +11.61% and over the past year by +41.58%.
Over the past week, the price has changed by +1.96%, over one month by +3.06%, over three months by +11.61% and over the past year by +41.58%.
Is BK a buy, sell or hold?
The Bank of New York Mellon has received a consensus analysts rating of 3.88.
Therefore, it is recommended to buy BK.
- StrongBuy: 5
- Buy: 5
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the BK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 132.6 | 10.6% |
| Analysts Target Price | 132.6 | 10.6% |
| ValueRay Target Price | 158.8 | 32.4% |
BK Fundamental Data Overview January 31, 2026
P/E Trailing = 16.2757
P/E Forward = 14.6628
P/S = 4.1761
P/B = 2.118
P/EG = 1.3101
Revenue TTM = 39.24b USD
EBIT TTM = 5.21b USD
EBITDA TTM = 8.36b USD
Long Term Debt = 32.30b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00b USD (from shortTermDebt, last quarter)
Debt = 33.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -97.64b USD (from netDebt column, last quarter)
Enterprise Value = -72.82b USD (83.99b + Debt 33.88b - CCE 190.69b)
Interest Coverage Ratio = 0.25 (Ebit TTM 5.21b / Interest Expense TTM 20.68b)
EV/FCF = -46.53x (Enterprise Value -72.82b / FCF TTM 1.56b)
FCF Yield = -2.15% (FCF TTM 1.56b / Enterprise Value -72.82b)
FCF Margin = 3.99% (FCF TTM 1.56b / Revenue TTM 39.24b)
Net Margin = 14.14% (Net Income TTM 5.55b / Revenue TTM 39.24b)
Gross Margin = 50.62% ((Revenue TTM 39.24b - Cost of Revenue TTM 19.38b) / Revenue TTM)
Gross Margin QoQ = 58.69% (prev 48.34%)
Tobins Q-Ratio = -0.15 (set to none) (Enterprise Value -72.82b / Total Assets 472.30b)
Interest Expense / Debt = 14.64% (Interest Expense 4.96b / Debt 33.88b)
Taxrate = 20.38% (376.0m / 1.84b)
NOPAT = 4.15b (EBIT 5.21b * (1 - 20.38%))
Current Ratio = 0.70 (Total Current Assets 272.49b / Total Current Liabilities 386.86b)
Debt / Equity = 0.76 (Debt 33.88b / totalStockholderEquity, last quarter 44.31b)
Debt / EBITDA = -11.68 (Net Debt -97.64b / EBITDA 8.36b)
Debt / FCF = -62.39 (Net Debt -97.64b / FCF TTM 1.56b)
Total Stockholder Equity = 43.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.25% (Net Income 5.55b / Total Assets 472.30b)
RoE = 12.66% (Net Income TTM 5.55b / Total Stockholder Equity 43.82b)
RoCE = 6.85% (EBIT 5.21b / Capital Employed (Equity 43.82b + L.T.Debt 32.30b))
RoIC = 5.68% (NOPAT 4.15b / Invested Capital 73.07b)
WACC = 9.84% (E(83.99b)/V(117.86b) * Re(9.10%) + D(33.88b)/V(117.86b) * Rd(14.64%) * (1-Tc(0.20)))
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.46%
[DCF Debug] Terminal Value 62.41% ; FCFF base≈1.56b ; Y1≈1.03b ; Y5≈468.7m
Fair Price DCF = 152.0 (EV 6.97b - Net Debt -97.64b = Equity 104.61b / Shares 688.2m; r=9.84% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 93.93 | EPS CAGR: 22.63% | SUE: 3.24 | # QB: 11
Revenue Correlation: 84.69 | Revenue CAGR: 24.27% | SUE: 3.03 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.90 | Chg30d=+0.090 | Revisions Net=+8 | Analysts=10
EPS current Year (2026-12-31): EPS=8.32 | Chg30d=+0.140 | Revisions Net=+12 | Growth EPS=+10.9% | Growth Revenue=+5.3%
EPS next Year (2027-12-31): EPS=9.35 | Chg30d=+0.185 | Revisions Net=+8 | Growth EPS=+12.3% | Growth Revenue=+4.5%
P/E Forward = 14.6628
P/S = 4.1761
P/B = 2.118
P/EG = 1.3101
Revenue TTM = 39.24b USD
EBIT TTM = 5.21b USD
EBITDA TTM = 8.36b USD
Long Term Debt = 32.30b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00b USD (from shortTermDebt, last quarter)
Debt = 33.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -97.64b USD (from netDebt column, last quarter)
Enterprise Value = -72.82b USD (83.99b + Debt 33.88b - CCE 190.69b)
Interest Coverage Ratio = 0.25 (Ebit TTM 5.21b / Interest Expense TTM 20.68b)
EV/FCF = -46.53x (Enterprise Value -72.82b / FCF TTM 1.56b)
FCF Yield = -2.15% (FCF TTM 1.56b / Enterprise Value -72.82b)
FCF Margin = 3.99% (FCF TTM 1.56b / Revenue TTM 39.24b)
Net Margin = 14.14% (Net Income TTM 5.55b / Revenue TTM 39.24b)
Gross Margin = 50.62% ((Revenue TTM 39.24b - Cost of Revenue TTM 19.38b) / Revenue TTM)
Gross Margin QoQ = 58.69% (prev 48.34%)
Tobins Q-Ratio = -0.15 (set to none) (Enterprise Value -72.82b / Total Assets 472.30b)
Interest Expense / Debt = 14.64% (Interest Expense 4.96b / Debt 33.88b)
Taxrate = 20.38% (376.0m / 1.84b)
NOPAT = 4.15b (EBIT 5.21b * (1 - 20.38%))
Current Ratio = 0.70 (Total Current Assets 272.49b / Total Current Liabilities 386.86b)
Debt / Equity = 0.76 (Debt 33.88b / totalStockholderEquity, last quarter 44.31b)
Debt / EBITDA = -11.68 (Net Debt -97.64b / EBITDA 8.36b)
Debt / FCF = -62.39 (Net Debt -97.64b / FCF TTM 1.56b)
Total Stockholder Equity = 43.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.25% (Net Income 5.55b / Total Assets 472.30b)
RoE = 12.66% (Net Income TTM 5.55b / Total Stockholder Equity 43.82b)
RoCE = 6.85% (EBIT 5.21b / Capital Employed (Equity 43.82b + L.T.Debt 32.30b))
RoIC = 5.68% (NOPAT 4.15b / Invested Capital 73.07b)
WACC = 9.84% (E(83.99b)/V(117.86b) * Re(9.10%) + D(33.88b)/V(117.86b) * Rd(14.64%) * (1-Tc(0.20)))
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.46%
[DCF Debug] Terminal Value 62.41% ; FCFF base≈1.56b ; Y1≈1.03b ; Y5≈468.7m
Fair Price DCF = 152.0 (EV 6.97b - Net Debt -97.64b = Equity 104.61b / Shares 688.2m; r=9.84% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 93.93 | EPS CAGR: 22.63% | SUE: 3.24 | # QB: 11
Revenue Correlation: 84.69 | Revenue CAGR: 24.27% | SUE: 3.03 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.90 | Chg30d=+0.090 | Revisions Net=+8 | Analysts=10
EPS current Year (2026-12-31): EPS=8.32 | Chg30d=+0.140 | Revisions Net=+12 | Growth EPS=+10.9% | Growth Revenue=+5.3%
EPS next Year (2027-12-31): EPS=9.35 | Chg30d=+0.185 | Revisions Net=+8 | Growth EPS=+12.3% | Growth Revenue=+4.5%